The Filing Desk

MannKind vs Pharming Group

MannKind MNKD · Pharming Group PHAR · Pharmaceuticals

Pharming Group reported revenue of $376 million in fiscal 2025, about the same as MannKind's $349 million in fiscal 2025. MannKind's revenue grew 22.2% in its latest year, and Pharming Group's grew 26.6%. MannKind had an operating margin of 11.1%, against 6.9% at Pharming Group. Free cash flow was $14 million at MannKind and $54 million at Pharming Group.

Side by side

MannKindPharming Group
Latest fiscal yearFY2025, Dec 31, 2025FY2025, Dec 31, 2025
Revenue$349M$376M
Revenue growth22.2%26.6%
Revenue growth a year, last 5 years39.9%12.1%
Gross margin92.3%87.9%
Operating margin11.1%6.9%
Net margin1.7%0.8%
Free cash flow$14M$54M
Free cash flow margin3.9%14.3%
Return on capital——
Net debt to EBITDA3.6x—
Dividends and buybacks$0M$0M
Change in diluted share count10.7%−4.9%
Last close$3.95$12.17
P/E at the last close——
Insider trades, last 12 monthsbought $259,000, sold $3.2 million—
Piotroski F-score4 of 9—
Amounts in each company's own currency, US$ unless marked (a foreign company may report in another), each company's latest fiscal year from its 10-K, or 20-F or 40-F for a foreign company. Growth rates compare with the year before; the five-year rate is the average a year. Free cash flow is cash from operations minus capital spending; return on capital is after-tax operating income over the money invested in the business; P/E is the last close over the latest earnings per share. Banks are measured differently (return on equity, efficiency ratio), so some rows apply to one company only.

Ten years

Revenue
US$ billions, fiscal years
MannKindPharming Group
Operating margin
Percent of revenue
MannKindPharming Group
Free cash flow
US$ billions. Cash from operations minus capital expenditure.
MannKindPharming Group

Start a new comparison

Source: the companies' Form 10-K filings, from SEC EDGAR, and the last close. For information only, not investment advice: the figures describe results, not which company is the better investment. The Filing Desk is not affiliated with either company. Full figures on the MannKind and Pharming Group pages.